Diversity of High-Level Aminoglycoside Resistance Mechanisms among Gram-Negative Nosocomial Pathogens in Brazil

Antimicrobial Agents and Chemotherapy
Anelise S BallabenYohei Doi

Abstract

No abstract listed.

References

May 25, 2004·Antimicrobial Agents and Chemotherapy·Yohei DoiYoshichika Arakawa
Sep 6, 2007·Antimicrobial Agents and Chemotherapy·Yohei DoiDavid L Paterson
Sep 14, 2010·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Maria S Ramirez, Marcelo E Tolmasky
Jul 12, 2012·The Journal of Antimicrobial Chemotherapy·Ea ZankariMette Voldby Larsen
Mar 25, 2014·International Journal of Antimicrobial Agents·Laís Lisboa CorrêaRenata Cristina Picão
Jan 19, 2016·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Alka HasaniHamid Reza Goli
May 22, 2016·Infectious Disease Clinics of North America·Yohei DoiYoshichika Arakawa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Related Papers

Rinsho byori. The Japanese journal of clinical pathology
T OguriN Kosakai
The Journal of Antimicrobial Chemotherapy
R C SpencerD M Harris
British Medical Bulletin
I Phillips, K Shannon
© 2022 Meta ULC. All rights reserved